Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind, multiple-dose, placebo-controlled study of BGP-15 in insulin-resistant patients
2005-000872-41Phase 2Completed
- Sponsor
- N-Gene Research & Development
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in insulin resistance (IR) and cardiometabolic risk (CMR) comparing BGP-15 with Placebo (2 arms). Primary endpoint: Change in insulin sensitivity by euglycemic clamp. Started Feb 2005; status: completed.
02
Drugs
BGP-15
03
Conditions
insulin resistance (IR)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2005-000872-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000872-41.